ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CYTK Cytokinetics Inc

62.10
-1.92 (-3.00%)
May 10 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,343,714
Bid Price 61.70
Ask Price 62.10
News (1)
Day High 64.61

Low
25.98

52 Week Range

High
110.25

Day Low 61.25
Company Name Stock Ticker Symbol Market Type
Cytokinetics Inc CYTK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.92 -3.00% 62.10 18:14:49
Open Price Low Price High Price Close Price Prev Close
63.63 61.25 64.61 62.10 64.02
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
19,343 1,343,714 $ 62.83 $ 84,431,048 - 25.98 - 110.25
Last Trade Time Type Quantity Stock Price Currency
19:58:07 1 $ 62.00 USD

Cytokinetics (CYTK) Options Flow Summary

Overall Flow

Bullish

Net Premium

112k

Calls / Puts

100.00%

Buys / Sells

50.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Cytokinetics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.4B 103.00M - 7.53M -526.24M -5.11 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cytokinetics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CYTK Message Board. Create One! See More Posts on CYTK Message Board See More Message Board Posts

Historical CYTK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week66.0868.4461.2564.741,187,172-3.98-6.02%
1 Month73.7673.7660.8665.451,191,834-11.66-15.81%
3 Months78.4681.3660.8668.251,927,887-16.36-20.85%
6 Months33.12110.2530.6872.212,782,65028.9887.50%
1 Year38.84110.2525.9861.691,902,69523.2659.89%
3 Years24.20110.2517.7248.411,405,86837.90156.61%
5 Years8.88110.257.72539.101,196,07553.22599.32%

Cytokinetics Description

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.

Your Recent History

Delayed Upgrade Clock